Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Search content at Johns Hopkins University
Home
Profiles
Research units
Research output
Dose intensity of chemotherapy for childhood cancers
Malcolm Smith
, Jeffrey Abrams
, Edward L. Trimble
, Richard S. Ungerleider
Research output
:
Contribution to journal
›
Article
›
peer-review
10
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Dose intensity of chemotherapy for childhood cancers'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chemotherapy
100%
Childhood Cancer
100%
Dose Intensity
100%
Tumor
75%
Dose Intensification
75%
Ewing Sarcoma
50%
Tumor Cells
50%
Pediatric Tumors
50%
Germ Cell Tumor
50%
Breast Cancer
25%
Improved Outcomes
25%
Ovarian Cancer
25%
Randomized Clinical Trial
25%
Therapeutic Implications
25%
Pediatric
25%
Clinical Trial Results
25%
Brain Tumor
25%
Cytotoxic Agents
25%
Children with Cancer
25%
Neuroblastoma
25%
Intensive Care Medicine
25%
Anticancer Therapy
25%
Biological Characteristics
25%
Alkylating Agents
25%
Short-term Costs
25%
Long-term Costs
25%
Dose-intensive
25%
Tumor Cancer
25%
General Acceptance
25%
Inherent Toxicity
25%
Pediatric Oncologists
25%
Cancer Treatment Strategies
25%
Medicine and Dentistry
Childhood Cancer
100%
Drug Dose Intensification
100%
Chemotherapy
100%
Ewing Sarcoma
66%
Tumor Cell
66%
Pediatric Cancer
66%
Germinoma
66%
Tumor
66%
Breast Cancer
33%
Neoplasm
33%
Health Care Cost
33%
Ovarian Cancer
33%
Malignant Neoplasm
33%
Pediatrics
33%
Clinical Trial Results
33%
Cancer Therapy
33%
Intensive Care
33%
Cancer Treatment
33%
Intracranial Tumor
33%
Ganglioneuroblastoma
33%
Alkylating Antineoplastic Agent
33%
Pediatric Oncologist
33%
Cytotoxic Agent
33%
Randomized Clinical Trials
33%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Chemotherapy Regimens
100%
Childhood Cancer
100%
Malignant Neoplasm
66%
Ewing Sarcoma
66%
Germ Cell Tumor
66%
Breast Cancer
33%
Randomized Clinical Trial
33%
Clinical Trial Results
33%
Intracranial Tumor
33%
Ovary Cancer
33%
Neuroblastoma
33%
Alkylating Agent
33%
Cytotoxic Agent
33%